Hyperparathyroidism, Primary

5

Review clinical trials related to Hyperparathyroidism, Primary. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Patient Navigation to Improve Surgical Access in Primary Hyperparathyroidism

The goal of this study is to address surgical health equity in historically marginalized participants with primary hyperparathyroidism (PHPT). The main questions that this study aims to answer are, how does patient navigation impact: * The proportion of PHPT participants undergo parathyroidectomy? * The proportion of PHPT participants who complete surgical consultation? * Time to surgical consultation? * Time to surgery?

Participants needed: 76
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University of PennsylvaniaUpdated: Jun 11, 2026Locations: 1
Eligibility criteria

Diagnosed with PHPT and not yet had parathyroidectomy who meet criteria for surg... [+1]

Prior Parathyroidectomy [+7]

Status: Not yet recruiting

Parathyroid Adenoma Detection With Rubidium-82 Imaging

Assess the uptake of rubidium-82 in parathyroid adenomas.

Participants needed: 20
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Matthieu Pelletier-Galarneau, MD MScUpdated: Aug 22, 2025Locations: 2
Eligibility criteria

Age ≥ 18y [+4]

Normocalcemic primary hyperparathyroidism [+3]

Status: Not yet recruiting

WHITE CAP: Intra-operative Parathyroid Tissue Sensor (PTS)-Guided Assessment of Parathyroid Viability and Surgical Decision-Making

Primary hyperparathyroidism is usually cured by removing the single over-active parathyroid adenoma. During surgery, however, surgeons often see a thin rim of normal parathyroid tissue that still "glows" under a near-infrared parathyroid tissue sensor (PTS). It is unclear whether keeping this tissue in place helps preserve hormone function or whether it leaves behind cells that could become over-active again. The WHITE CAP study will compare two common surgical choices: Preservation strategy - the surgeon removes only the adenoma and leaves the glowing rim of normal tissue untouched. En-bloc strategy - the surgeon removes the adenoma together with the glowing rim; if too little parathyroid tissue remains, a small fragment is transplanted into the forearm muscle. About 120 adult patients who have a single parathyroid adenoma will be randomly assigned (like tossing a coin) to one of the two strategies. All operations will use the same FDA-cleared PTS camera that shows the glands in real time without dye or radiation. The main question is whether preserving the normal rim lowers the rate of temporary low blood-calcium (numbness, tingling) during the first two days after surgery. The study will also check long-term results-blood calcium and parathyroid hormone (PTH) levels, symptoms, and any return of the disease-over two years. The PTS imaging itself is painless and adds only a few minutes to the operation. Risks are the same as for standard parathyroid surgery, and participants can withdraw at any time without affecting their usual care.

Participants needed: 120
Trial details
Age: 18-75Biological sex: AllType: InterventionalSponsor: Fujian Medical UniversityUpdated: Jun 29, 2025Locations: 1
Eligibility criteria

Age 18 to 75 years, able to give informed consent. [+3]

Multiple endocrine neoplasia (MEN 1 or 2) or suspicion of multi-gland disease (>... [+5]

Status: Recruiting

Autofluorescence in Surgery for Primary Hyperparathyroidism

The study aims to test if autofluorescence imaging (AF) is a useful surgical aid during parathyroidectomy (PTX) for primary hyperthyroidism (PHPT).

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Aarhus University HospitalUpdated: Jan 29, 2025Locations: 1
Eligibility criteria

Age>18 years and able to give informed consent. [+2]

Concordant high-confidence imaging; planned focused/selective PTX [+5]

Status: Not yet recruiting

The Bone-parathyroid Crosstalk in Primary Hyperparathyroidism

The PARABONE study aims to investigate the interaction between bone and parathyroid glands in patients with primary hyperparathyroidism (HPT). The study consists of a clinical part aimed at evaluating a series of circulating molecules of bone derivation (osteocalcin, molecules of the WNT pathway, RANKL, osteoprotegerin, Scelrostin, FGF23) in patients with HPT. In particular, the study has as its primary objective to identify the correlation between circulating levels of PTH and levels of GlaOC and GluOC in patients with HPT.

Participants needed: 100
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: I.R.C.C.S Ospedale Galeazzi-Sant'AmbrogioUpdated: Sep 30, 2022Locations: 1
Eligibility criteria

diagnosis of primary hyperparathyroidism according to the most recent guidelines... [+5]

age <18 years [+3]